Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

Creso Pharma Limited

Investor presentation - Creso Pharma Limited

ASX:CPH

Creso Pharma Limited

Health

Creso Pharma Limited (CPH) aims to develop register, and commercialize pharmaceutical-grade cannabis- and hemp-based products and treatments, to the highest GMP quality standards. Company's strategy is to leverage science and research to develop, register and commercialize new cannabis and hemp-derived therapeutic products based on solid scientific data. Company provide safe high grade CBD therapeutic products which are unique in composition, standardized in formulation and dose, and administered by proprietary delivery technologies which fulfill the necessary requirements for efficacy, safety, highest quality and consistency.

Read more

Market Cap

$209.83m

Price at Close

$0.23

4w avg. Volume

19.53m

4w avg. Turnover

$4.58m

Announcements
announcementt+2 movementdate
  • Update - Proposed issue of Securities - CPH

    Issued Capital

  • -

    20 Jan 2021

-

20 Jan 2021
  • Update - Proposed issue of Securities - CPH

    Issued Capital

  • -

    20 Jan 2021

-

20 Jan 2021
  • Update - Proposed issue of Securities - CPH

    Issued Capital

  • -

    20 Jan 2021

-

20 Jan 2021
  • Prospectus

    Issued Capital

  • -

    20 Jan 2021

-

20 Jan 2021
  • Creso secures POs for record start to FY2021

    Periodic Reports · Market sensitive

  • +4.55%

    18 Jan 2021

+4.55%

18 Jan 2021
  • Appendix 2A

    Issued Capital

  • +4.35%

    15 Jan 2021

+4.35%

15 Jan 2021
  • CPH secures $320,000 revenue from second PO in South Africa

    Progress Report

  • -2.17%

    11 Jan 2021

-2.17%

11 Jan 2021
  • Appendix 2A

    Issued Capital

  • -2.17%

    11 Jan 2021

-2.17%

11 Jan 2021
  • Becoming a substantial holder

    Shareholder Details

  • -2.17%

    11 Jan 2021

-2.17%

11 Jan 2021
  • Proposed issue of Securities - CPH

    Issued Capital

  • -2.17%

    11 Jan 2021

-2.17%

11 Jan 2021
Market Data

Current Price

$0.23

52WK HIGH

$0.47

52WK LOW

$0.024

1YR RETURN

+27.78%

1YR RETURN VS. SECTOR

-9.25%

90 DAY RETURN

+693.10%

ASX RANK

607

/2,048

SECTOR RANK

48

/168

SHARES OUTSTANDING

912.30m
ASX:CPH

Creso Pharma Limited

Health

Creso Pharma Limited (CPH) aims to develop register, and commercialize pharmaceutical-grade cannabis- and hemp-based products and treatments, to the highest GMP quality standards. Company's strategy is to leverage science and research to develop, register and commercialize new cannabis and hemp-derived therapeutic products based on solid scientific data. Company provide safe high grade CBD therapeutic products which are unique in composition, standardized in formulation and dose, and administered by proprietary delivery technologies which fulfill the necessary requirements for efficacy, safety, highest quality and consistency.

Read more

Market Cap

$209.83m

Price at Close

$0.23

4w avg. Volume

19.53m

4w avg. Turnover

$4.58m

ASX:CPH is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.